BioVentures Investors, LLC is a private equity and venture capital firm specializing in special situations and seed stage investments. The firm also considers investments in public equity opportunities that hold the potential for venture-level returns. It primarily invests in medtech,life sciences and healthcare companies. Within these sectors, the firm invests in human therapeutics, medical devices, and diagnostics sectors. It prefers is to invest in a company at the first institutional round. The firm seeks to invest between $5 million and $8 million in its portfolio companies. It typically acts as an active investor. The firm seeks to led or co-led and take a seat on the board of directors of its portfolio companies. It prefers to exit its investments within five years. BioVentures Investors, LLC was founded in 1999 and is based in Cambridge, Massachusetts.

BioVentures Investors

Co-Founder and Managing Partner

MD - Investor Development

Venture Partner - Asia

Co-Founder and Venture Partner

Principal

Venture Partner

CoNextions Medical raised $2163000 on 2017-03-16 in Venture Round

CoNextions Medical, Inc. manufactures tendon repair surgical healthcare equipment. It offers CoNextionsTR, a stainless steel and ultra-high molecular weight polyethylene implant that is designed for the surgically address tendon injuries. The company was founded in 2011 and is headquartered in Salt Lake City, Utah.

CoNextions Medical, Inc.

Pintex Pharmaceuticals raised $7250000 on 2002-12-24 in Series B

Pintex Pharmaceuticals, Inc. is a private pharmaceuticals company headquartered in Watertown, MA., that is engaged in the discovery and development of structure-based cancer therapeutics. In particular, the focus of Pintex's research is on the phosphate specific proline isomerase Pin1 enzyme and its key role in cancer. Pintex was founded in May 1999 by Dr. Kun Ping Lu, a Pew scholar at Harvard University, Dr. Walter Gilbert, a Nobel Prize winning professor at Harvard University and Dr. Janusz Sowadski, co-founder of Kinetix Pharmaceuticals, Inc., and a past recipient of the US Supercomputing Award for structure-based kinase inhibitor designs. Pintex was created in order to harness the many years of research and discovery performed and patented by researchers at the Salk Institute for Biological Studies and Harvard University.

Pintex Pharmaceuticals

Cylene Pharmaceuticals raised $12000000 on 2010-09-24 in Series D

Cylene Pharmaceuticals, Inc., a biotech pharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs that target nucleolus and kill cancer cells. It offers nucleolus targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric brain tumors; and serine/threonine protein kinase inhibitors. The company also provides pre-clinical stage oral drug candidates. Cylene Pharmaceuticals, Inc. was founded in 1997 as Cyternex, Inc. and changed its name to Cylene Pharmaceuticals, Inc. in October 2003. The company is based in San Diego, California.

Cylene Pharmaceuticals

Hydra Biosciences raised $22000000 on 2009-01-16 in Series D

Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in novel ion channels. Hydra's proprietary high throughput screening platforms enable the company to identify and develop drug candidates that address significant unmet medical needs.

Hydra's ion channel drug discovery program is currently focused on channels implicated in pain, inflammation, and cardiovascular disease. Hydra's intellectual property portfolio, significant ion channel expertise, and flexible screening systems set it apart from other biopharmaceutical companies. Unlike classical sodium, calcium, or potassium voltage-gated channels Hydra's novel ion channels provide the potential to develop selective and safer ion channel drugs.

Hydra has raised significant financing from blue-chip investors since its inception. This prominent group of investors includes Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec, Boston Medical Investors, and MedImmune Ventures.

Hydra Biosciences

Verax Biomedical raised $15000000 on 2005-10-14 in Series B

Verax Biomedical, Incorporated, a medical products company, develops rapid tests for the detection of bacterial contaminants in blood cells and tissues for transplantation and cellular therapies. It offers platelet, red cell, and cell therapy pan genera detection (PGD) tests. The company was founded in 1999 and is based in Marlborough, Massachusetts.

Verax Biomedical

Cardiosolutions raised $7000000 on 2007-09-26 in Series A

Cardiosolutions, Inc. designs and develops a product for mitral regurgitation problem. The company develops Mitra-Spacer, a reversible implantable device that provides a sealing surface for the leaflets of the mitral valve, thereby reducing or eliminating mitral regurgitation. It serves patients of various ages who suffer from moderate to severe mitral regurgitation, including those who are currently in congestive heart failure. Cardiosolutions, Inc. was founded in 2005 and is based in West Bridgewater, Massachusetts.

Cardiosolutions, Inc.

Enanta Pharmaceuticals raised $12000000 on 2004-01-14 in Venture Round

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company offers glecaprevir for the treatment of chronic hepatitis C virus, or HCV under the MAVYRET and MAVIRET names. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.

Enanta Pharmaceuticals

Enanta Pharmaceuticals raised $20000000 on 2004-08-31 in Venture Round

Hydra Biosciences raised $18870000 on 2004-01-12 in Series B

Pintex Pharmaceuticals raised an undisclosed amount on 2002-04-19 in Series A

Claros Diagnostics raised $4000000 on 2009-03-23 in Series B

Claros Diagnostics, Inc. is creating products to move in-vitro medical diagnostic tests out of the laboratory and into the hands of physicians and patients.

Claros Diagnostics

Ardais Corporation raised $14000000 on 2003-01-13 in Series C

Ardais Corporation is a clinical genomics company, is dedicated to enhancing and accelerating biomedical research by introducing actual human disease into the pharmaceutical discovery research process. To achieve its goals, Ardais has incorporated multi-disciplinary scientific expertise into its operations, including pathology, molecular biology and genomics, statistical genomics, bioinformatics and medical informatics, as well as process management skills such as logistics, industrial engineering, and robotics. The result of this unique integration is a state-of-the-art, proprietary discovery platform that is dramatically transforming genomic research and leading the way to novel diagnostic and therapeutic solutions.

Ardais Corporation

Verax Biomedical raised $4500000 on 2003-07-21 in Series A

Angiolink Corporation raised $13600000 on 2003-09-10 in Series B

Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.

Angiolink Corporation

Claros Diagnostics raised $7800000 on 2007-01-19 in Series A

Verax Biomedical raised $3000000 on 2007-06-21 in Venture Round

Unified Information Devices raised $2460000 on 2018-07-10 in Venture Round

Unified Information Devices, Inc. develops and manufactures laboratory animal identification devices and solutions. The products include implantable transponders, microchips, external transponders, readers, multiple tag programmers, and customized software. The company was incorporated in 2014 and is based in Lake Villa, Illinois.

Unified Information Devices, Inc.

Hydrocision raised an undisclosed amount on 2010-09-15 in Venture Round

HydroCision develops, manufactures, and markets fluidjet based surgical tools for minimally invasive spine surgery requirements. Its products include SpineJet HydroSurgery System that is used to ablate, cut, and remove targeted tissue for spinal procedures, Spinejet, water-based technology solutions for minimally invasive spine surgery requirements, SpineJet HydroDiscectomy Systems, which are used to remove tissue without the risk of thermal energy for minimally invasive discectomy procedures, and AlloJet, systems to prepare bone allografts. The company also provides customer care services. HydroCision, Inc. was formerly known as Surgijet Corporation and changed its name to HydroCision, Inc. in November 1996. The company was founded in 1994 and is headquartered in North Billerica, Massachusetts.

HydroCision, Inc.

Endotronix raised $70000000 on 2018-09-14 in Series D

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure.

It was founded in 2007 and is based in Lisle, Illinois.

ENDOTRONIX

InSeal Medical raised an undisclosed amount on 2012-01-02 in Venture Round

InSeal Medical Ltd. develops and manufactures percutaneous vascular closure devices. The company offers InSeal intravascular closure device, which supports the closure of 14-21Fr punctures in vessels of 6-10mm in diameter. Its devices are used for sealing of puncture sites following treatment involving a large bore sheath. The company is based in Caesarea, Israel. InSeal Medical Ltd. operates as a subsidiary of E-Pacing Inc.

InSeal Medical

Endotronix raised $32000000 on 2016-07-05 in Series C

Spirus Medical raised $8500000 on 2007-04-19 in Series B

Spirus Medical is a developer of advanced care medical devices for the gastrointestinal and cardiovascular markets. The company’s product portfolio includes the Endo-Ease  Discovery and Dexterity Steerable Introducer.

Spirus Medical

BRAINBox Solutions raised $23000000 on 2020-12-08 in Series A

BRAINBox Solutions, Inc. develops and manufactures traumatic brain injury (TBI) tests for the diagnosis and prognosis of mild traumatic brain injury. It offers BRAINBox Solutions, a multi-modality approach that includes blood biomarker panels, neurocognitive testing, and point of care instruments. The company also provides quantitative test that combines injury-related blood protein biomarkers with computerized neurological assessments. BRAINBox Solutions, Inc. was founded in 2002 and is based in Richmond, Virginia.

BRAINBox Solutions, Inc.

Hydra Biosciences raised $34000000 on 2008-03-13 in Series C

Cylene Pharmaceuticals raised $44000000 on 2007-01-23 in Series C

POC Medical Systems raised $21000000 on 2017-01-10 in Series A

Testing that is performed near or at the site of patient care with the result leading to possible change in the course of care of the patient. Testing that is performed outside a central laboratory environment, generally nearer to, or at the site of the patient. Also referred to as “near-patient” testing, or “point-of-need testing

POC Medical Systems

Sciona raised $9900000 on 2006-04-03 in Series C

Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Sciona

Kanova raised $16568695 on 2018-11-26 in Series A

Kanova

Angiolink Corporation raised $10600000 on 2002-09-17 in Series A

Nano-Micro Technology raised an undisclosed amount on 2015-01-01 in Series A

Nano-Micro Technology is a hardware company, which provides uniformly sized nano- and microspheres.

Nano-Micro Technology

Verax Biomedical raised $2540000 on 2007-12-17 in Series E

Cylene Pharmaceuticals raised $26300000 on 2005-05-26 in Series B

Verax Biomedical raised $4500000 on 2002-05-29 in Series A

Phase Forward raised $25000000 on 2000-08-24 in Venture Round

Provider of integrated data collection and data management solutions for clinical trials and drug safety

Phase Forward

Sonomotion raised $10000000 on 2019-11-12 in Series B

SonoMotion Inc. develops non-invasive solutions for kidney stone disease. It offers Break Wave, which fragments large kidney stones; and Stone Clear that helps clear the resulting stone fragments within 15 minutes in an office setting and also without general anesthesia or X-ray radiation. SonoMotion Inc. was founded in 2012 and is based in San Mateo, California.

SonoMotion Inc.

Sciona raised $3400000 on 2007-06-08 in Venture Round